CHF-6366 is a potent M3 muscarinic antagonist and beta2-adrenergic receptors agonist with pKi values of 10.4 and 11.4, respectively. CHF-6366 is also a weak calcium channel inhibitor (IC50~50 µM). CHF-6366 inhibits bronchoconstriction in guinea pigs. CHF-6366 can be used to research chronic obstructive pulmonary disease (COPD)[1].
Molekulargewicht:
764.87
CAS Nummer:
[1615208-41-7]
Formel:
C42H48N6O8
Target-Kategorie:
Adrenergic Receptor,Calcium Channel,mAChR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten